A detailed history of Deutsche Bank Ag\ transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 2,112,745 shares of GOSS stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,112,745
Previous 3,807,661 44.51%
Holding current value
$1.48 Million
Previous $3.43 Million 38.97%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.79 - $1.25 $1.34 Million - $2.12 Million
-1,694,916 Reduced 44.51%
2,112,745 $2.09 Million
Q4 2023

Feb 14, 2024

BUY
$0.48 - $1.08 $1.83 Million - $4.11 Million
3,807,661 New
3,807,661 $3.46 Million
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.53 $46,082 - $71,945
-47,023 Reduced 22.49%
162,038 $194,000
Q1 2023

May 15, 2023

BUY
$0.96 - $2.92 $10,019 - $30,476
10,437 Added 5.25%
209,061 $263,000
Q4 2022

Feb 13, 2023

BUY
$1.74 - $12.87 $13,545 - $100,192
7,785 Added 4.08%
198,624 $431,000
Q3 2022

Nov 14, 2022

BUY
$7.21 - $14.88 $1.1 Million - $2.26 Million
151,901 Added 390.11%
190,839 $2.29 Million
Q2 2022

Aug 11, 2022

SELL
$5.97 - $9.97 $6,131 - $10,239
-1,027 Reduced 2.57%
38,938 $326,000
Q1 2022

May 13, 2022

SELL
$8.44 - $12.49 $177,771 - $263,076
-21,063 Reduced 34.51%
39,965 $347,000
Q4 2021

Feb 11, 2022

BUY
$10.12 - $14.07 $13,125 - $18,248
1,297 Added 2.17%
61,028 $690,000
Q3 2021

Nov 04, 2021

BUY
$7.25 - $13.23 $115,644 - $211,031
15,951 Added 36.43%
59,731 $751,000
Q2 2021

Aug 11, 2021

BUY
$8.0 - $9.75 $14,640 - $17,842
1,830 Added 4.36%
43,780 $356,000
Q1 2021

May 13, 2021

SELL
$8.63 - $10.94 $27,978 - $35,467
-3,242 Reduced 7.17%
41,950 $388,000
Q4 2020

Feb 16, 2021

SELL
$8.3 - $13.59 $1.17 Million - $1.92 Million
-141,093 Reduced 75.74%
45,192 $437,000
Q3 2020

Nov 12, 2020

SELL
$11.3 - $14.75 $1.84 Million - $2.4 Million
-162,824 Reduced 46.64%
186,285 $2.31 Million
Q2 2020

Aug 13, 2020

BUY
$9.52 - $15.98 $3.19 Million - $5.35 Million
334,810 Added 2341.49%
349,109 $4.54 Million
Q1 2020

May 14, 2020

SELL
$8.0 - $15.48 $6,520 - $12,616
-815 Reduced 5.39%
14,299 $146,000
Q4 2019

Feb 14, 2020

BUY
$14.82 - $26.79 $45,423 - $82,111
3,065 Added 25.44%
15,114 $235,000
Q3 2019

Nov 14, 2019

SELL
$16.02 - $22.47 $120,438 - $168,929
-7,518 Reduced 38.42%
12,049 $201,000
Q2 2019

Aug 14, 2019

BUY
$16.12 - $22.89 $88,869 - $126,192
5,513 Added 39.23%
19,567 $431,000
Q1 2019

May 15, 2019

BUY
$17.58 - $23.97 $247,069 - $336,874
14,054 New
14,054 $303,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $65.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.